Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
Chest ; 149(6): 1525-34, 2016 06.
Article in English | MEDLINE | ID: mdl-26836925

ABSTRACT

A link between metabolic syndrome (MetS) and lung diseases has been observed in several cross-sectional and longitudinal studies. This syndrome has been identified as an independent risk factor for worsening respiratory symptoms, greater lung function impairment, pulmonary hypertension, and asthma. This review will discuss several potential mechanisms to explain these associations, including dietary factors and the effect of adiposity and fat-induced inflammation on the lungs, and the role of other comorbidities that frequently coexist with MetS, such as OSA and obesity. In contrast to the well-known association between asthma and obesity, the recognition that MetS affects the lung is relatively new. Although some controversy remains as to whether MetS is a unique disease entity, its individual components have independently been associated with changes in pulmonary function or lung disease. There is, however, uncertainty as to the relative contribution that each metabolic factor has in adversely affecting the respiratory system; also, it is unclear how much of the MetS-related lung effects occur independently of obesity. In spite of these epidemiological limitations, the proposed mechanistic pathways strongly suggest that this association is likely to be causal. Given the wide prevalence of MetS in the general population, it is imperative that we continue to further understand how this metabolic disorder impacts the lung and how to prevent its complications.


Subject(s)
Lung Diseases , Metabolic Syndrome/epidemiology , Comorbidity , Humans , Lung Diseases/epidemiology , Lung Diseases/physiopathology , Lung Diseases/prevention & control , Prevalence , Preventive Medicine/methods , Respiratory Function Tests/methods , Risk Factors
3.
AIDS Patient Care STDS ; 24(1): 23-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20095902

ABSTRACT

Syphilis outbreaks in the United States have been reported since 2000 with highest rates in the South and many cases among HIV-infected individuals. We evaluated incident syphilis cases and concurrent gonorrhea and chlamydia screening at a southern HIV clinic. A retrospective cohort study included HIV-infected patients with at least one reactive plasma reagin (test for serum reagin antibodies to cardiolipin-cholesterol-lecithin antigen) and primary care visit from July 2004 to June 2007. Primary, secondary, and early latent syphilis cases were identified as incident syphilis and evaluation for gonorrhea and chlamydia within 1 month were described. Logistic regression was performed to determine factors associated with incident syphilis. Among 1544 patients, 40 incident syphilis cases were identified (5 primary, 29 secondary, and 6 early latent). The majority of patients were not virologically suppressed and only 25% had gonorrhea and chlamydia testing. In adjusted analyses, younger age (0.57 per 10 years, 95% confidence interval [CI] 0.41-0.80) and minority race (2.26, 95% CI 1.12-4.59) were associated with incident syphilis. Among 40 incident syphilis cases, only 1 in 4 were further tested for gonorrhea and chlamydia. These low rates are concerning as concurrent sexually transmitted infections (STIs) increase risk for HIV transmission. HIV care provider education with emphasis on STI testing in the setting of incident syphilis is key in prevention.


Subject(s)
HIV Infections/complications , Syphilis/complications , Syphilis/diagnosis , Adult , Age Distribution , Alabama/epidemiology , Female , HIV Infections/epidemiology , Humans , Male , Middle Aged , Odds Ratio , Risk Factors , Syphilis/epidemiology , United States/epidemiology , Young Adult
4.
Mil Med ; 174(6): 652-6, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19585783

ABSTRACT

Hansen's disease (HD), formerly referred to as leprosy, actively infects more than 250,000 persons worldwide, with over 2 million currently being treated for sequelae. Over 150 cases are annually reported in the U.S. Although transmission of Hansen's disease to military personnel is rare, physicians caring for those who deploy abroad should be aware of the diagnostic challenges and therapeutic aspects of the disease, as well as its implication for continued military service. Additionally, with U.S. involvement in humanitarian efforts abroad, many military physicians will encounter this condition in indigenous populations. Because of its relative rarity in the U.S. and its protean manifestations, diagnosis is generally delayed 6-12 months, leading to potentially irreversible sequelae. Therefore the clinician should be aware of the presentation of HD as well as the key steps to procuring a diagnosis. This paper reports a case of HD encountered in an active duty, native-born U.S. Air Force aviator.


Subject(s)
Leprosy/diagnosis , Military Personnel , Mycobacterium leprae , Adult , Diagnosis, Differential , Humans , Leprostatic Agents/therapeutic use , Leprosy/drug therapy , Leprosy/pathology , Male , Military Medicine , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...